Sign in
4

Changes in Ownership

MADRIGAL PHARMACEUTICALS, INC. Filed Acc 0001179110-11-006920

Sr. VP, Drug Development sold 20,000 shares at an average $5.80 ($116,000)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Koya Keizo Sr. VP, Drug Development 2011-04-20 Sale −10,000 $5.60 $56,000 29,843 D: show line 1 in the form
Koya Keizo Sr. VP, Drug Development 2011-04-25 Sale −10,000 $6.00 $60,000 19,843 D: show line 2 in the form
Open-market sales · 20,000 sh · avg $5.80 · $116,000
Loading xslF345X03/edgar.xml…